National Comprehensive Cancer Network

Chemotherapy Order Template

Kidney Cancer

Gemcitabine/CARBOplatin

KDN5

INDICATION:

Metastatic or Relapsed – Collecting Duct/Medullary Subtypes

REFERENCES:

  1. NCCN Guidelines® for Kidney Cancer. V.3.2015.
  2. Oudard S, et al. J Urol. 2007;177(5):1698-702. a

NCCN SUPPORTIVE CARE:

  1. Emetic Risk:
    Day 1 Moderate
    Day 8 Low
  2. Fever Neutropenia Risk:
    Refer to NCCN Guidelines for Myeloid Growth Factors. V.2.2014

CHEMOTHERAPY REGIMEN

21-day cycle for 6 cycles

  • Gemcitabine 1250 mg/m2 IV over 30 minutes on Days 1 and 8
  • CARBOplatin AUC 5 IV over 30 minutes on Day 1
<type> <text value="Chemotherapy Order Template"/> </type> <status value="draft"/> <experimental value="true"/> <publisher value="National Comprehensive Cancer Network, Inc."/> <approvalDate value="2016-07-27"/> <lastReviewDate value="2016-07-27"/> <!-- Indications --> <useContext> <extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"> <valueString value="A"/> </extension> <code> <system value="http://example.org/fhir/CodeSystem/indications"/> <code value="treamentSetting-or-diseaseStatus"/> </code> <valueCodeableConcept> <text value="Metastatic"/> </valueCodeableConcept> </useContext> <useContext> <extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"> <valueString value="A"/> </extension> <code> <system value="http://example.org/fhir/CodeSystem/indications"/> <code value="disease-or-histology"/> </code> <valueCodeableConcept> <text value="Collecting Duct/Medullary Subtypes"/> </valueCodeableConcept> </useContext> <useContext> <extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"> <valueString value="A"/> </extension> <code> <system value="http://hl7.org/fhir/usage-context-type"/> <code value="focus"/> </code> <valueCodeableConcept> <text value="Kidney Cancer"/> </valueCodeableConcept> </useContext> <useContext> <extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"> <valueString value="B"/> </extension> <code> <system value="http://example.org/fhir/CodeSystem/indications"/> <code value="treatmentSetting-or-diseaseStatus"/> </code> <valueCodeableConcept> <text value="Relapsed"/> </valueCodeableConcept> </useContext> <useContext> <extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"> <valueString value="B"/> </extension> <code> <system value="http://example.org/fhir/CodeSystem/indications"/> <code value="disease-or-histology"/> </code> <valueCodeableConcept> <text value="Collecting Duct/Medullary Subtypes"/> </valueCodeableConcept> </useContext> <useContext> <extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"> <valueString value="B"/> </extension> <code> <system value="http://hl7.org/fhir/usage-context-type"/> <code value="focus"/> </code> <valueCodeableConcept> <text value="Kidney Cancer – Collecting Duct/Medullary Subtypes - Metastatic"/> </valueCodeableConcept> </useContext> <contributor> <type value="author"/> <name value="Lee Surprenant"/> </contributor> <copyright value="All rights reserved."/> <!-- list of references for the order template --> <relatedArtifact> <type value="derived-from"/> <display value="NCCN Guidelines for Kidney Cancer. V.2.2016"/> <url value="http://www.example.org/professionals/physician_gls/PDF/kidney.pdf"/> </relatedArtifact> <relatedArtifact> <type value="citation"> <extension url="http://example.org/fhir/regimenReferenceType"> <valueCode value="a"/> </extension> </type> <citation value="Oudard S, et al. J Urol. 2007;177(5):1698-702"/> <url value="http://www.ncbi.nlm.nih.gov/pubmed/17437788"/> </relatedArtifact> <action> <!-- list of regimen options. in this case only one --> <selectionBehavior value="exactly-one"/> <action> <!-- list of regimen parts. in this case only one --> <selectionBehavior value="all"/> <action> <!-- list of cycle definitions. in this case only one --> <groupingBehavior value="sentence-group"/> <selectionBehavior value="exactly-one"/> <action id="cycle-definition-1"> <textEquivalent value="21-day cycle for 6 cycles"/> <timingTiming> <repeat> <count value="6"/> <duration value="21"/> <durationUnit value="d"/> </repeat> </timingTiming> <!-- list of regimen entry references for this regimen part --> <!-- references would duplicated in each cycle definition option (see http://hl7.org/fhir/STU3/codesystem-action-grouping-behavior.html#sentence-group) --> <action id="action-1"> <extension url="http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"> <extension url="day"> <valueInteger value="1"/> </extension> <extension url="day"> <valueInteger value="8"/> </extension> </extension> <textEquivalent value="Gemcitabine 1250 mg/m² IV over 30 minutes on days 1 and 8"/> <definition> <reference value="#1111"/> </definition> </action> <action id="action-2"> <extension url="http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"> <extension url="day"> <valueInteger value="1"/> </extension> </extension> <textEquivalent value="CARBOplatin AUC 5 IV over 30 minutes on Day 1"/> <relatedAction> <actionId value="action-1"/> <relationship value="concurrent-with-start"/> </relatedAction> <definition> <reference value="#2222"/> </definition> </action> <!-- end of regimen entries --> </action> <!-- end of cycle definitions --> </action> <!-- end of regimen parts --> </action> <!-- end of regimen options --> </action> </PlanDefinition>